Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling

Kanchan Chitaley, R Clinton Webb

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

NO induces vasodilation through cGMP-dependent protein kinase-dependent and-independent mechanisms. A recent study demonstrated that recombinant cGMP-dependent protein kinase can phosphorylate the small G protein, RhoA, thus inhibiting its activity. Additionally, sodium nitroprusside was found to reverse the phenylephrine-induced translocation of RhoA, which is further indicative of the inhibition of RhoA activity. RhoA is known to be involved in the Ca2+ sensitization of vascular smooth muscle through the actions of one of its downstream effectors, Rho-kinase. This study examined whether NO endogenously induces the relaxation of intact rat aorta via the inhibition of the Rho-kinase-mediated Ca2+-sensitizing pathway. Endogenous Rho-kinase inhibitor activity was inhibited by the selective compound Y-27632. Treatment of endothelium-intact rat aorta with Y-27632 (1 μmol/L) resulted in an attenuation of maximal force generated in response to phenylephrine. In endothelium-denuded rings, however, 1 μmol/L Y-27632 was ineffective at inhibiting the phenylephrine-induced contraction. Additionally, 1 μmol/L Y-27632 was significantly less effective at inhibiting the phenylephrine-induced contraction of endothelium-intact rings in the presence of inhibitors of NO synthase or guanylate cyclase (Nω-nitro-L-arginine and 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one, respectively). Interestingly, sodium nitroprusside restored the ability of 1 μmol/L Y-27632 to attenuate phenylephrine-induced contraction. Rho-kinase inhibition was also found to increase the sensitivity of the endothelium-denuded aorta to sodium nitroprusside. These data demonstrate that NO inhibits Rho-kinase activity in the intact rat aorta, supporting the hypothesis that endogenous NO-mediated vasodilation occurs through the inhibition of Rho-kinase constrictor activity in the intact rat aorta.

Original languageEnglish (US)
Pages (from-to)438-442
Number of pages5
JournalHypertension
Volume39
Issue number2 II
DOIs
StatePublished - Mar 4 2002

Fingerprint

rho-Associated Kinases
Phenylephrine
Aorta
Dilatation
Nitric Oxide
Endothelium
Nitroprusside
Cyclic GMP-Dependent Protein Kinases
Vasodilation
Monomeric GTP-Binding Proteins
Guanylate Cyclase
Vascular Smooth Muscle
Nitric Oxide Synthase
Arginine
Y 27632

Keywords

  • Kinase
  • Muscle, smooth, vascular
  • Nitric oxide
  • Vasodilation

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling. / Chitaley, Kanchan; Webb, R Clinton.

In: Hypertension, Vol. 39, No. 2 II, 04.03.2002, p. 438-442.

Research output: Contribution to journalArticle

@article{7d282bac366e4703bfa83de2c970e874,
title = "Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling",
abstract = "NO induces vasodilation through cGMP-dependent protein kinase-dependent and-independent mechanisms. A recent study demonstrated that recombinant cGMP-dependent protein kinase can phosphorylate the small G protein, RhoA, thus inhibiting its activity. Additionally, sodium nitroprusside was found to reverse the phenylephrine-induced translocation of RhoA, which is further indicative of the inhibition of RhoA activity. RhoA is known to be involved in the Ca2+ sensitization of vascular smooth muscle through the actions of one of its downstream effectors, Rho-kinase. This study examined whether NO endogenously induces the relaxation of intact rat aorta via the inhibition of the Rho-kinase-mediated Ca2+-sensitizing pathway. Endogenous Rho-kinase inhibitor activity was inhibited by the selective compound Y-27632. Treatment of endothelium-intact rat aorta with Y-27632 (1 μmol/L) resulted in an attenuation of maximal force generated in response to phenylephrine. In endothelium-denuded rings, however, 1 μmol/L Y-27632 was ineffective at inhibiting the phenylephrine-induced contraction. Additionally, 1 μmol/L Y-27632 was significantly less effective at inhibiting the phenylephrine-induced contraction of endothelium-intact rings in the presence of inhibitors of NO synthase or guanylate cyclase (Nω-nitro-L-arginine and 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one, respectively). Interestingly, sodium nitroprusside restored the ability of 1 μmol/L Y-27632 to attenuate phenylephrine-induced contraction. Rho-kinase inhibition was also found to increase the sensitivity of the endothelium-denuded aorta to sodium nitroprusside. These data demonstrate that NO inhibits Rho-kinase activity in the intact rat aorta, supporting the hypothesis that endogenous NO-mediated vasodilation occurs through the inhibition of Rho-kinase constrictor activity in the intact rat aorta.",
keywords = "Kinase, Muscle, smooth, vascular, Nitric oxide, Vasodilation",
author = "Kanchan Chitaley and Webb, {R Clinton}",
year = "2002",
month = "3",
day = "4",
doi = "10.1161/hy02t2.102960",
language = "English (US)",
volume = "39",
pages = "438--442",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2 II",

}

TY - JOUR

T1 - Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling

AU - Chitaley, Kanchan

AU - Webb, R Clinton

PY - 2002/3/4

Y1 - 2002/3/4

N2 - NO induces vasodilation through cGMP-dependent protein kinase-dependent and-independent mechanisms. A recent study demonstrated that recombinant cGMP-dependent protein kinase can phosphorylate the small G protein, RhoA, thus inhibiting its activity. Additionally, sodium nitroprusside was found to reverse the phenylephrine-induced translocation of RhoA, which is further indicative of the inhibition of RhoA activity. RhoA is known to be involved in the Ca2+ sensitization of vascular smooth muscle through the actions of one of its downstream effectors, Rho-kinase. This study examined whether NO endogenously induces the relaxation of intact rat aorta via the inhibition of the Rho-kinase-mediated Ca2+-sensitizing pathway. Endogenous Rho-kinase inhibitor activity was inhibited by the selective compound Y-27632. Treatment of endothelium-intact rat aorta with Y-27632 (1 μmol/L) resulted in an attenuation of maximal force generated in response to phenylephrine. In endothelium-denuded rings, however, 1 μmol/L Y-27632 was ineffective at inhibiting the phenylephrine-induced contraction. Additionally, 1 μmol/L Y-27632 was significantly less effective at inhibiting the phenylephrine-induced contraction of endothelium-intact rings in the presence of inhibitors of NO synthase or guanylate cyclase (Nω-nitro-L-arginine and 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one, respectively). Interestingly, sodium nitroprusside restored the ability of 1 μmol/L Y-27632 to attenuate phenylephrine-induced contraction. Rho-kinase inhibition was also found to increase the sensitivity of the endothelium-denuded aorta to sodium nitroprusside. These data demonstrate that NO inhibits Rho-kinase activity in the intact rat aorta, supporting the hypothesis that endogenous NO-mediated vasodilation occurs through the inhibition of Rho-kinase constrictor activity in the intact rat aorta.

AB - NO induces vasodilation through cGMP-dependent protein kinase-dependent and-independent mechanisms. A recent study demonstrated that recombinant cGMP-dependent protein kinase can phosphorylate the small G protein, RhoA, thus inhibiting its activity. Additionally, sodium nitroprusside was found to reverse the phenylephrine-induced translocation of RhoA, which is further indicative of the inhibition of RhoA activity. RhoA is known to be involved in the Ca2+ sensitization of vascular smooth muscle through the actions of one of its downstream effectors, Rho-kinase. This study examined whether NO endogenously induces the relaxation of intact rat aorta via the inhibition of the Rho-kinase-mediated Ca2+-sensitizing pathway. Endogenous Rho-kinase inhibitor activity was inhibited by the selective compound Y-27632. Treatment of endothelium-intact rat aorta with Y-27632 (1 μmol/L) resulted in an attenuation of maximal force generated in response to phenylephrine. In endothelium-denuded rings, however, 1 μmol/L Y-27632 was ineffective at inhibiting the phenylephrine-induced contraction. Additionally, 1 μmol/L Y-27632 was significantly less effective at inhibiting the phenylephrine-induced contraction of endothelium-intact rings in the presence of inhibitors of NO synthase or guanylate cyclase (Nω-nitro-L-arginine and 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one, respectively). Interestingly, sodium nitroprusside restored the ability of 1 μmol/L Y-27632 to attenuate phenylephrine-induced contraction. Rho-kinase inhibition was also found to increase the sensitivity of the endothelium-denuded aorta to sodium nitroprusside. These data demonstrate that NO inhibits Rho-kinase activity in the intact rat aorta, supporting the hypothesis that endogenous NO-mediated vasodilation occurs through the inhibition of Rho-kinase constrictor activity in the intact rat aorta.

KW - Kinase

KW - Muscle, smooth, vascular

KW - Nitric oxide

KW - Vasodilation

UR - http://www.scopus.com/inward/record.url?scp=0036181829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036181829&partnerID=8YFLogxK

U2 - 10.1161/hy02t2.102960

DO - 10.1161/hy02t2.102960

M3 - Article

VL - 39

SP - 438

EP - 442

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2 II

ER -